Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
European Respiratory Review : an Official Journal of the European Respiratory Society|July 13, 2018
Bronchiectasis: a case-based approach to investigation and managementMartina Contarini, Simon Finch, James D Chalmers
Current Opinion in Pharmacology|February 14, 2021
Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutationAndrea Gramegna, Martina Contarini, Francesco Bindo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 3, 2021
Prevalence and serotyping of S. pneumoniae in a large vaccine-naive cohort of adults with cystic fibrosisAndrea Gramegna, Stefano Aliberti, Leonardo Terranova, et al.
International Journal of Molecular Sciences|August 23, 2020
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic FibrosisAndrea Gramegna, Martina Contarini, Stefano Aliberti, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 22, 2019
The biology of pulmonary exacerbations in bronchiectasisFrancesco Amati, Edoardo Simonetta, Andrea Gramegna, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 22, 2022
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case seriesAndrea Gramegna, Claudia De Petro, Gloria Leonardi, et al.
Biomedicines|December 23, 2022
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center ExperienceFrancesco Amati, Andrea Gramegna, Martina Contarini, et al.
Expert Opinion on Pharmacotherapy|April 28, 2026
Pharmacotherapy options and drug development in bronchiectasis: spotlight on dipeptidyl-peptidase inhibitorsChiara Premuda, Andrea Gramegna, Sofia Misuraca, et al.
Therapeutic Advances in Respiratory Disease|November 25, 2024
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disordersFrancesco Amati, Gloria Leonardi, Martina Contarini, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 10, 2024
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosisGianfranco Alicandro, Andrea Gramegna, Federica Bellino, et al.
Pageof 2